NIH begins clinical trial of hydroxychloroquine and azithromycin to treat COVID-19

A clinical trial has begun to evaluate whether the malaria drug hydroxychloroquine, given together with the antibiotic azithromycin, can prevent hospitalization and death from coronavirus disease 2019 (COVID-19). The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is sponsoring the trial, which is being conducted by the NIAID-funded…

Online exercise advice rarely aligns with national physical activity guidelines

CORVALLIS, Ore. — Whether for convenience, cost or comfort, many people look to online resources for fitness and exercise information — especially when faced with fitness center and gym closures during the COVID-19 pandemic. Unfortunately, most internet-based recommendations for physical activity don’t match up with the guidelines supported by national health organizations, a recent study…

Tracking an organism’s development, cell by cell

Scientists at the Stem Cell Research program at Boston Children’s Hospital and Dana-Farber Cancer Institute/Harvard Medical School have devised a mouse model that lets researchers track every cell in the body, from the embryonic stage until adulthood. Using a “barcoding” technique and CRISPR gene editing technology, the model can identify different cell types as they…

BioCompute Object Specification Project receives IEEE Standardization Acceptance

WASHINGTON (May 14, 2020) – The BioCompute Object Specification Project led by a team at the George Washington University has been officially approved for publication as an internationally recognized standard by the Institute of Electrical and Electronics Engineers (IEEE) Standards Association. Standardization will open the door to government agencies and large institutions formalizing the process…

SCAI issues device selection guidelines for aorto-iliac arterial interventions

WASHINGTON – The Society for Cardiovascular Angiography and Interventions (SCAI) has released guidelines that provide a comprehensive review of comparative effectiveness data for devices used in aorto-iliac arterial interventions. The recommendations aim to provide clinicians with guidance for device selection in patients for whom these devices are intended as definitive therapy. The document was published…

SCAI releases official position statement on optimal percutaneous interventional therapy for complex coronary artery disease

WASHINGTON – The Society for Cardiovascular Angiography and Interventions (SCAI) has published a position statement addressing optimal percutaneous coronary intervention (PCI) treatment of patients with complex coronary artery disease (CAD). The position statement was presented today during the SCAI 2020 Scientific Sessions Virtual Conference and published in SCAI’s official journal, Catheterization and Cardiovascular Interventions. While…